Despite recent advances in the treatment of human heart failure, the overall impact on morbidity and mortality has been limited, and heart failure remains the pre-eminent cardiovascular health problem in the country. Limitations in our understanding can be attributed, in part, to the inability to examine basic mechanisms in appropriate animal models in which the progressive pathogenesis of hypertrophy and heart failure can be studied. Thus, the overall aim of this Program Project is to identify physiological, biochemical and molecular mechanisms which are fundamental to the progression from imposition of the abnormal load to development of compensated hypertrophy to heart failure. A secondary goal is to understand the mechanism of potential therapeutic agents within the context of the pathogenesis of hypertrophy and heart failure. To achieve these goals, we will focus primarily on the study of transgenic mice and pigs. The organization of the Program Project includes 4 projects and 4 cores. The physiological studies contained in Project 1 examine mechanisms of altered myocardial function in ventricular hypertrophy and failure. An additional component of Project 1 is to understand the mechanisms of cardiac dysfunction in terms of energy metabolism. Accordingly, NMR technology will complement the work on integrative physiology. Project 2 emphasizes altered beta-adrenergic receptor signalling and signalling mechanisms involving stress-activated protein kinases in hypertrophy and heart failure. Both of these projects will study transgenic animal models, including that of cardiac Gsalpha overexpression, which develops cardiomyopathy later in life. Project 3 is designed to provide novel information on molecular mechanisms of adenylyl cyclase regulation, also using transgenic models. Project 4 focuses on novel sarcomeric protein mutation-induced cardiomyopathies. Thus, this Program Project represents a multi-disciplinary approach to the problems of myocardial hypertrophy and heart failure combining expertise in integrative physiology and cellular and molecular biology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL059139-02
Application #
2771616
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
1997-09-15
Project End
1999-06-30
Budget Start
1998-09-01
Budget End
1999-06-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Yamamoto, Takanobu; Byun, Jaemin; Zhai, Peiyong et al. (2014) Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS One 9:e98972
Matsushima, Shouji; Kuroda, Junya; Ago, Tetsuro et al. (2013) Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1? and upregulation of peroxisome proliferator-activated receptor-?. Circ Res 112:1135-49
Zablocki, Daniela; Sadoshima, Junichi (2013) Angiotensin II and oxidative stress in the failing heart. Antioxid Redox Signal 19:1095-109
Hariharan, Nirmala; Ikeda, Yoshiyuki; Hong, Chull et al. (2013) Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One 8:e51632
Zschauer, Tim-Christian; Matsushima, Shouji; Altschmied, Joachim et al. (2013) Interacting with thioredoxin-1--disease or no disease? Antioxid Redox Signal 18:1053-62
Maejima, Yasuhiro; Kyoi, Shiori; Zhai, Peiyong et al. (2013) Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med 19:1478-88
Del Re, Dominic P; Yang, Yanfei; Nakano, Noritsugu et al. (2013) Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem 288:3977-88
Herman, Daniel S; Lam, Lien; Taylor, Matthew R G et al. (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366:619-28
Sciarretta, Sebastiano; Zhai, Peiyong; Shao, Dan et al. (2012) Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation 125:1134-46
Oka, Shin-Ichi; Hsu, Chiao-Po; Sadoshima, Junichi (2012) Regulation of cell survival and death by pyridine nucleotides. Circ Res 111:611-27

Showing the most recent 10 out of 192 publications